Gink­go Bioworks ap­points a vet­er­an as its new SVP of bio­phar­ma man­u­fac­tur­ing

While the syn­thet­ic play­er Gink­go Bioworks made waves last year on Wall Street with a record SPAC deal, the com­pa­ny’s lat­est move will see it hun­ker­ing down on its man­u­fac­tur­ing ca­pa­bil­i­ties with its lat­est hire.

The com­pa­ny has brought on Be­hzad Mah­davi as the se­nior vice pres­i­dent of bio­phar­ma man­u­fac­tur­ing and life sci­ences tools. The role will have Mah­davi lead Gink­go’s com­mer­cial ef­forts in bio-reagents as well as cell and gene ther­a­py man­u­fac­tur­ing and oth­er bio­phar­ma­ceu­ti­cals.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER